Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Healthcare News.
Press releases published on August 28, 2025
Nurix Therapeutics to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
LEXINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of …
Ascendis Pharma to Participate in the 2025 Wells Fargo Healthcare Conference
COPENHAGEN, Denmark, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, at 8:00 a.m …
Carlsmed® Reports Second Quarter 2025 Financial Results
Q2’25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled …
Alignment Health CEO Named “Founder of the Year” at 2025 LA Times Studios’ OC Executive Forum & Leadership Awards
ORANGE, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Alignment Health today announced that its founder and CEO, John Kao, has been named “Founder of the Year” by LA Times Studios at the 2025 Orange County Executive Forum …
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market
Strategic Move Positions YD Bio Limited for Accelerated Innovation and Market Expansion Trading of common stock and warrants of the new public company, YD Bio Limited, is expected to commence on the Nasdaq Global Market on August 29, 2025, under the ticker …
Tilray Medical renforce sa présence en Allemagne en introduisant de nouvelles variétés de cannabis thérapeutique Good Supply
LONDRES et NEUMÜNSTER, 28 août 2025 (GLOBE NEWSWIRE) -- Tilray Medical (« Tilray »), une division de Tilray Brands, Inc. (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique qui permet aux patients et aux professionnels de santé de …
Tilray Medical erweitert Präsenz in Deutschland durch Einführung neuer medizinischer Cannabissorten von Good Supply
LONDON und NEUMÜNSTER, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tilray Medical („Tilray“), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führendes Unternehmen im Bereich des medizinischen Cannabis, das die …
Raina Biosciences Unveils Breakthrough Generative AI Platform for mRNA Therapeutics Featured in Science
– GEMORNA is world’s first generative AI platform purpose-built for mRNA design and optimization, demonstrating state-of-the-art performance across diverse mRNA therapeutic applications – – GEMORNA designs optimized mRNA sequences efficiently, …
Service Coordination, Inc. Welcomes Laura J.V. Kamosa to Board of Directors
Frederick, MD, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Service Coordination, Inc. (SCI), one of Maryland’s largest case management organizations for people with disabilities and complex medical needs, is proud to announce the appointment of Laura J.V. Kamosa, …
Hodgkin’s Lymphoma Market Set to Reach New Heights by 2034 with Innovative Therapies and Clinical Successes | DelveInsight
New York, USA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Hodgkin’s Lymphoma Market Set to Reach New Heights by 2034 with Innovative Therapies and Clinical Successes | DelveInsight The Hodgkin’s lymphoma market is witnessing steady growth driven by rising …
Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight
New York, USA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight Antisense oligonucleotides (ASOs) are gaining …
Cirtec Medical Announces Appointment of New Chief Executive Officer
BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of Shar Matin as …
PruittHealth Expands Commitment to Senior Care with Acquisition in Warner Robins
WARNER ROBINS, Ga., Aug. 28, 2025 (GLOBE NEWSWIRE) -- PruittHealth, a family-owned and Georgia-based provider in post-acute health care and senior services, announced today its continued expansion into Warner Robins with the acquisition of The Lodge of …
Ergodyne Launches New Hi-Vis Accessories to Help Combat Struck-By Incidents from Workday to Weekend
St. Paul, MN, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Ergodyne, makers of Tenacious Work Gear®, has expanded its hi-vis line with a collection of accessories designed to help people stay seen and stay safe in high-risk, low-visibility environments. This latest …
Gene and Oral Therapies Drive Urgency and Innovation in Retinal Care, Reshaping Ophthalmology’s Future, According to Spherix Global Insights
Exton, Pennsylvania, Aug. 28, 2025 (GLOBE NEWSWIRE) -- In a newly published edition of Special Topix™: Ophthalmology Pipeline Opportunities 2025 (US), research from Spherix Global Insights with U.S. ophthalmologists, including retina specialists, sheds …
Zealand Pharma to participate in upcoming investor conferences in September 2025
Press release – No. 12 / 2025 Zealand Pharma to participate in upcoming investor conferences in September 2025 Copenhagen, Denmark, August 28, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and …
Urgent Appeal: Freeze CERN Funding, Fund Innovations Suppressed for 32 Years That Can Save Millions of Lives and Billions of Euros
DALLAS, Aug. 28, 2025 (GLOBE NEWSWIRE) -- (In PDF: https://bit.ly/3UCW8XE) The Crosetto Foundation for the Reduction of Cancer Deaths, a registered nonprofit organization, urgently calls on the public to help expose and correct scientific and institutional …
Despite Early Low Awareness, Physicians Forecast Swift Adoption of Novo Nordisk’s Wegovy in MASH, According to Spherix Global Insights
EXTON, PA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The recent approval of Novo Nordisk’s Wegovy (semaglutide 2.4mg) as the second treatment for metabolic dysfunction-associated steatohepatitis (MASH) represents a critical step forward in a condition with a vast …